| 产品描述: | 强效双重FAAH / MAGL抑制剂;Potent dual FAAH/MAGL inhibitor;JZL195是有效的FAAH和MAGL抑制剂,IC50分别为2 nM和4 nM;JZL195 has been used:as a selective inhibitor of endocannabinoid (eCB) clearance enzymes to induce in vivo long-term depression at CA3-CA1 synapses and at prelimbic (PrL)-nucleus accumbens (NAc)synapses, to study the neuroprotective action of eCB
to inhibit the action of hydrolytic enzymes that limit eCB activity, to study the effect of 2-linoleoylglycerol (2-LG) on the human CB1 receptor activity
as a dual fatty acid amide hydrolase (FAAH)/monoacylglycerol lipase (MAGL) inhibitor to study its dose-related antipruritic effect on the serotonin (5-HT)-induced scratching model |
| 靶点: |
IC50: 2 nM (FAAH), 4 nM (MAGL) |
| 体内研究: |
JZL195 (20 mg/kg;腹腔注射) 在尾部浸没试验中产生镇痛反应。 |
| 参考文献: |
1. Long JZ, et al. Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20270-5. 2. Anderson WB, et al. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model. Neuropharmacology. 2014 Jun;81:224-30. |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.307 ml |
11.534 ml |
23.068 ml |
| 5 mM |
0.461 ml |
2.307 ml |
4.614 ml |
| 10 mM |
0.231 ml |
1.153 ml |
2.307 ml |
| 50 mM |
0.046 ml |
0.231 ml |
0.461 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |